Compare WSO & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSO | ZBH |
|---|---|---|
| Founded | 1945 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 19.9B |
| IPO Year | N/A | N/A |
| Metric | WSO | ZBH |
|---|---|---|
| Price | $348.13 | $94.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 19 |
| Target Price | ★ $435.00 | $108.56 |
| AVG Volume (30 Days) | 381.1K | ★ 2.1M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.45% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 12.87 | 4.03 |
| Revenue | $7,414,495,000.00 | ★ $8,010,900,000.00 |
| Revenue This Year | N/A | $8.20 |
| Revenue Next Year | $4.21 | $5.92 |
| P/E Ratio | $27.01 | ★ $23.38 |
| Revenue Growth | N/A | ★ 5.47 |
| 52 Week Low | $323.05 | $85.33 |
| 52 Week High | $535.40 | $114.44 |
| Indicator | WSO | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 49.85 |
| Support Level | $337.73 | $92.14 |
| Resistance Level | $356.99 | $98.34 |
| Average True Range (ATR) | 10.38 | 1.99 |
| MACD | 2.70 | 0.49 |
| Stochastic Oscillator | 73.88 | 58.27 |
Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of revenue), with significant exposure in the Sun Belt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.